Evaluation of anti-Yersinia psueudotuberculosis-derived mitogen antibody in intravenous immunoglobulin products. Issue 11 (November 2022)

• Record Type: Journal Article
• Authors: Miyata, Ippei; Kato, Atsushi; Ouchi, Kazunobu
• Is Part Of: Journal of infection and chemotherapy. Volume 28:Issue 11(2022)
• Page Start: 1582
• Page End: 1583
• Publication Date: 2022-11
• Subjects: Yersinia pseudotuberculosis -- ELISA -- Intravenous immunoglobulin -- Serological testing -- Superantigen; Chemotherapy -- Periodicals; Infection -- Periodicals; Communicable diseases -- Chemotherapy -- Periodicals; 615.5805
• DOI: 10.1016/j.jiac.2022.07.020
• Languages: English
• ISSNs: 1341-321X

Abstract

Abstract: Antibody titers against the superantigen, Yersinia pseudotuberculosis -derived mitogen, suggestive of mediating Kawasaki disease-like manifestation in Y. pseudotuberculosis infections, in immunoglobulin products were evaluated. Trace, but detectable titer was demonstrated in the products. Thus, attention is required when evaluating anti- Y. pseudotuberculosis -derived mitogen IgG titers in patient sera post intravenous immunoglobulin therapy.